Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone

Pharmacy World and Science

Volumn 27, Issue 2, 2005, Pages 81-82

  Suda, Katie J ^b   Garey, Kevin W ^a   Danziger, Larry H ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b Metro Pharmacy Administration   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antacids; Ciprofloxacin; Divalent cations; Drug interactions; Fluoroquinolones; Levofloxacin

Indexed keywords

ALUMINUM HYDROXIDE; AMIKACIN; CALCIUM CARBONATE; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DIVALENT CATION; FAMOTIDINE; FERROUS GLUCONATE; LEVOFLOXACIN; MAGNESIUM HYDROXIDE; MAGNESIUM OXIDE; MULTIVITAMIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCRALFATE;

ACINETOBACTER BAUMANNII; ADULT; ANAMNESIS; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HAEMOPHILUS INFLUENZAE; HEALTH PRACTITIONER; HEARTBURN; HUMAN; LABORATORY TEST; MALE; OSTEOMYELITIS; PANTOEA AGGLOMERANS; PLEURA EMPYEMA; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; TREATMENT FAILURE;

ADMINISTRATION, ORAL; AGED; ANTI-BACTERIAL AGENTS; CATIONS, DIVALENT; DIABETES MELLITUS, TYPE 2; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HEART DISEASES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT EDUCATION; TREATMENT FAILURE;

EID: 19944404751     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-004-7040-0     Document Type: Article

References (12)

1. GG Zhanel K Ennis L Vercaigne 2002 A critical review of the fluoroquinolones: focus on respiratory infections Drugs 62 13 59
2. K. Garey K. Rodvold 2000 Drug-Food Interactions SC Piscitelli KA Rodvold Drug Interactions in Infectious Diseases Humana Press Totowa. NJ ISBN 0-89603-750-9.
3. M Kara BB Hasinoff DW McKay NR. Campbell 1991 Clinical and chemical interactions between iron preparations and ciprofloxacin Br J Clin Pharmacol 31 257 61
4. Y Mizuki I Fujiwara T. Yamaguchi 1996 Pharmacokinetic interactions related to the chemical structures of fluoroquinolones J Antimicrob Chemoth 37 (Suppl A 41 55
5. RW Frost KC Lasseter AJ Noe EC Shamblen JT. Lettieri 1992 Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin Antimicrob Agents Chemoth 36 830 2
6. JC Garrelts PJ Godley JD Peterie EH Gerlach CC. Yakshe 1990 Sucralfate significantly reduces ciprofloxacin concentrations in serum Antimicrob Agents Chemoth 34 931 3
7. LJ Lee B Hafkin ID Lee J Hoh R. Dix 1997 Effects of food and sucralfate on a single oral dose of 500∈mg of levofloxacin in healthy subjects Antimicrob Agents Chemother 41 2196 200
8. S Lober S Ziege M Rau 1999 Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium Antimicrob Agents Chemoth 43 1067 71
9. DE Nix WA Watson L Handy RW Frost DL Rescott HR. Goldstein 1989 The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin Pharmacotherapy 9 377 80
10. DE Nix WA Watson ME Lener 1989 Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin Clin Pharmacol Ther 46 700 5
11. AW Wallace JM Victory GW. Amsden 2003 Lack of bioequivalence when levofloxacin and calcium-fortified orange juice are coadministered to healthy volunteers J Clin Pharmacol 43 539 44
12. AW Wallace JM Victory GW. Amsden 2003 Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers J Clin Pharmacol 43 92 6